Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen
Evidence-based pain therapy should rely on precisely defined and personalized criteria. This includes balancing the benefits and risks not only of single drugs but often requires complex between-drug comparisons. Non-steroidal anti-inflammatory drugs (NSAIDs) have been available for several decades...
Saved in:
Main Authors: | André Farkouh (Author), Margit Hemetsberger (Author), Christian R. Noe (Author), Christoph Baumgärtel (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring Deep Eutectic Solvents as Pharmaceutical Excipients: Enhancing the Solubility of Ibuprofen and Mefenamic Acid
by: Mihaela-Alexandra Nica, et al.
Published: (2024) -
To study the efficacy and safety of diosmin with tranexamic acid and mefenamic acid versus only tranexamic acid and mefenamic acid in medical management of abnormal uterine bleeding: A randomized controlled trial
by: J B Sharma, et al.
Published: (2023) -
Ibuprofen versus steroids: risk and benefit, efficacy and safety
by: M. Giovannini, et al.
Published: (2013) -
Mefenamic Acid Induced Nephrotoxicity: An Animal Model
by: Muhammad Nazrul Somchit, et al.
Published: (2014) -
Effects of the Combination of Nigella Sativa and Mefenamic Acid and Mefenamic Acid Alone on the Severity of Postpartum Pain in Multiparous Women: A Double-Blind Clinical Trial
by: Maryam Chananeh, et al.
Published: (2018)